Orthogonal Ubiquitin Transfer for E3 Substrate Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying substrates of E3 ubiquitin ligases are inefficient due to complex cross-reactions among E2s and E3s, leading to difficulties in differentiating direct substrates from other interacting proteins and background ubiquitination, which affects the accuracy of substrate assignment.
Innovation Solution
The implementation of orthogonal ubiquitin transfer (OUT) using variant ubiquitin (UB), variant ubiquitin activating enzyme (E1), and variant ubiquitin-conjugating enzyme (E2) components, which interact specifically and orthogonally, allowing for the identification of direct substrates by expressing and purifying UB-conjugated proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional substrate identification methods (affinity binding, monitoring protein stability, E3 fusions) are used, then substrates can be identified, but cross-reactions among E2s and E3s create background interference and reduce identification accuracy
Solution Approach 1:
The ubiquitin cascade is segmented into orthogonal systems. The patent uses engineered ubiquitin (xUB) with unique amino acid sequences that cannot be recognized by wild-type E1-E2-E3 complexes, creating a dedicated tracking system. This segmentation allows specific substrates to be identified without interference from cross-reactions involving endogenous ubiquitin components.
Solution Approach 2:
The patent introduces engineered intermediary components (xE1, xE2, xUB) that mediate the ubiquitin transfer process. These engineered intermediaries serve as a controlled system to track substrate ubiquitination specifically, eliminating the need to distinguish between direct E3 substrates and indirect interactors in the complex cellular environment.
2Adaptability or versatility
If affinity-based approaches (co-immunoprecipitation, yeast two-hybrid, protein microarray) are used to identify E3 substrates, then interacting proteins can be detected, but substrates cannot be differentiated from adaptors and regulators
Solution Approach 1:
The patent employs a detectable signal system analogous to color changes. Engineered ubiquitin (xUB) is conjugated to substrates through the orthogonal xE1-xE2-xE3 cascade, and this conjugation can be detected by specific antibodies or probes that recognize the engineered ubiquitin sequence. This provides a direct visual and detectable signal for substrate identification, distinguishing true substrates from adaptors and regulators that do not receive the engineered ubiquitin signal.
3Reliability
If activity-based approaches monitoring protein stability are used, then ubiquitination changes can be tracked, but most ubiquitin chains encode non-degradation signals and global ubiquitination changes cannot assign direct substrates to specific E3s
Solution Approach 1:
The patent performs preliminary action by expressing and purifying the engineered ubiquitin (xUB) before it can be transferred to substrates in the cell. The xUB is first activated by xE1 to form a stable thioester conjugate, which is then transferred to xE2 and subsequently to the substrate. This controlled preliminary preparation ensures that any detected xUB-conjugated proteins are direct substrates of the engineered E3, eliminating ambiguity about direct vs. indirect relationships.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
OUT method effectively eliminates cross-reactions and accurately assigns substrates by directly tracking UB transfer from E3 to its target proteins, reducing background interference and improving substrate identification precision.
Implementation Method 1
E1 first activates UB to form a UB ̃E1 thioester conjugate with the C-terminal carboxylate of UB bonded to a catalytic Cys residue of E1
Implementation Method 2
Next, UB is transferred to a catalytic Cys residue on E2 to form a UB ̃E2 conjugate
Implementation Method 3
E3 that recruits substrate proteins and catalyzes isopeptide bond formation between the C-terminal Gly of UB and Lys residues on the substrates
Data Source
AI summary
Disclosed herein are compounds, compositions, and methods for identifying substrates of E3 ubiquitin ligases. The proteins, vectors, compositions, and may be utilized in methods for orthogonal ubiquitin transfer (OUT) between variant components of the ubiquitin cascade such as a variant ubiquitin (UB), a variant ubiquitin activating enzyme (E1), a variant ubiquitin-conjugating enzyme (E2), and a variant ubiquitin ligase (E3), which may include a variant HECT type, U-box type, RBR type, and/or Ring type E3 ligase. The variant components of the ubiquitin cascade typically include one or more mutations relative to their wild-type counterparts, such as amino acid substitutions, such that the variant components interact specifically and orthogonally with each of their variant components and do not interact with the wild-type counterpart of their variant components.